Reber Genetics Co Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Reber Genetics Co Ltd with three other
pharmaceutical manufacturers in Asia:
Body Organ Biomedical Corp
sales of 25.53 million Taiwanese Dollars [US$826,499.50 ]
Cho Pharma Inc
(396,000.00 Taiwanese Dollars [US$12,822.48 ]
Syncore Biotechnology Co Ltd
(8.14 million Taiwanese Dollars [US$263,702.72 ]
Reber Genetics Co Ltd reported sales of 30.33 million Taiwanese Dollars (US$982.21 thousand)
December of 2017.
decrease of 13.4%
versus 2016, when the company's sales were 35.02 million Taiwanese Dollars.